We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+13.97%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$4.74B
AUM Growth
-$4.89B
Cap. Flow
-$187M
Cap. Flow %
-3.95%
Top 10 Hldgs %
49.48%
Holding
1,228
New
25
Increased
10
Reduced
14
Closed
23

Top Buys

Rank Stock Value
1
DHR.PRA
Danaher Corporation 4.75% Mandatory Convertible Preferred Stock, Series A
DHR.PRA
+$5.9M
2
SPLK
Splunk Inc
SPLK
+$2.26M
3
COUP
Coupa Software Incorporated
COUP
+$2.15M
4
BKNG icon
Booking.com
BKNG
+$1.8M
5
PPLI
People Inc
PPLI
+$1.64M

Top Sells

Rank Stock Value
1
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$11.1M
2
Z icon
Zillow
Z
+$3.18M
3
AGN
Allergan plc
AGN
+$2.69M
4
RNG icon
RingCentral
RNG
+$2.07M
5
REXR icon
Rexford Industrial Realty
REXR
+$2.04M

Sector Composition

Rank Sector Weight
1 Real Estate 58.33%
2 Technology 5.66%
3 Healthcare 4.64%
4 Consumer Discretionary 4.34%
5 Communication Services 4.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SYNH
1001
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
$23K ﹤0.01%
586
– –
RETA
1002
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$22K ﹤0.01%
153
– –
PS
1003
DELISTED
Pluralsight, Inc. Class A Common Stock
PS
$22K ﹤0.01%
2,040
– –
IOVA icon
1004
Iovance Biotherapeutics
IOVA
$2.12B
$21K ﹤0.01%
712
– –
MOMO
1005
Hello Group
MOMO
$869M
$21K ﹤0.01%
960
– –
ADPT icon
1006
Adaptive Biotechnologies
ADPT
$3.63B
$20K ﹤0.01%
702
– –
BBIO icon
1007
BridgeBio Pharma
BBIO
$16.6B
$20K ﹤0.01%
697
– –
MRTX
1008
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$19K ﹤0.01%
242
– –
BPMC
1009
DELISTED
Blueprint Medicines
BPMC
$18K ﹤0.01%
301
– –
BYND icon
1010
Beyond Meat
BYND
$280M
$18K ﹤0.01%
265
– –
FPI
1011
Farmland Partners
FPI
$422M
$18K ﹤0.01%
3,000
– –
NKTR icon
1012
Nektar Therapeutics
NKTR
$2.39B
$18K ﹤0.01%
66
– –
MNTA
1013
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$18K ﹤0.01%
653
– –
ARGX icon
1014
argenx
ARGX
$55.5B
$17K ﹤0.01%
129
– –
COHR icon
1015
PUT
Coherent
COHR
$45.9B
$17K ﹤0.01%
+500
New +$19.8K
KYNB
1016
Kyntra Bio
KYNB
$28.8M
$17K ﹤0.01%
20
– –
HLF icon
1017
PUT
Herbalife
HLF
$1.3B
$17K ﹤0.01%
+260
New +$10.1K
PRDO icon
1018
Perdoceo Education
PRDO
$2.03B
$17K ﹤0.01%
1,530
– –
GBT
1019
DELISTED
Global Blood Therapeutics, Inc.
GBT
$17K ﹤0.01%
340
– –
ARWR icon
1020
Arrowhead Research
ARWR
$11.9B
$16K ﹤0.01%
566
– –
PR
1021
Permian Resources
PR
$16.9B
$16K ﹤0.01%
59,480
– –
PTCT icon
1022
PTC Therapeutics
PTCT
$6.15B
$16K ﹤0.01%
348
– –
IMMU
1023
DELISTED
Immunomedics Inc
IMMU
$16K ﹤0.01%
1,190
– –
MEDP icon
1024
Medpace
MEDP
$16.7B
$15K ﹤0.01%
203
– –
GWPH
1025
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$15K ﹤0.01%
166
– –
39 40
41
42 43

Similar funds

SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

Daiwa Securities Group's Q2 2020 Portfolio in Review

As of Q2 2020, Daiwa Securities Group held 1,228 positions worth $4.74B, down 51% from $9.64B the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Daiwa Securities Group withdrew a net $187M in Q2 2020, closing 23 positions and reducing 14 holdings. Its most notable exit was Berkshire Hathaway Class B, an estimated $11.1M position sold in full.

By sector, the portfolio is most concentrated in Real Estate at 58% of assets, down from 71% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Daiwa Securities Group opened a new position in Danaher Corporation 4.75% Mandatory Convertible Preferred Stock, Series A worth $6.27M.

  • Daiwa Securities Group's largest Q2 2020 buy was Danaher Corporation 4.75% Mandatory Convertible Preferred Stock, Series A: 5,000 shares worth $6.27M.
  • Daiwa Securities Group added most to Splunk Inc in Q2 2020, an estimated $2.26M increase.
  • Daiwa Securities Group's biggest Q2 2020 reduction was Zillow, cutting an estimated $3.18M.
  • Daiwa Securities Group fully exited Berkshire Hathaway Class B in Q2 2020, selling an estimated $11.1M.
  • Daiwa Securities Group's ten largest holdings make up 49% of its $4.74B portfolio in Q2 2020.
  • Daiwa Securities Group opened 25 new positions and closed 23 in Q2 2020.
  • Daiwa Securities Group's portfolio value fell 51% quarter-over-quarter to $4.74B.

Based on Daiwa Securities Group's 13F filing for Q2 2020, filed 11 Aug 2020.